Deutsche Bank Ag\ Olema Pharmaceuticals, Inc. Transaction History

Deutsche Bank Ag\

$240 Billion
Q3 2024

A detailed history of Deutsche Bank Ag\ transactions in Olema Pharmaceuticals, Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 27,132 shares of OLMA stock, worth $238,218. This represents 0.0% of its overall portfolio holdings.

Number of Shares

27,132

Previous 253,874 89.31%

Holding current value

$238,218

Previous $2.75 Million 88.24%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$10.41 - $16.46 $2.36 Million - $3.73 Million	-226,742 Reduced 89.31%	27,132 $323,000
Q2 2024 Aug 14, 2024	BUY	$8.73 - $13.99 $42,288 - $67,767	4,844 Added 1.95%	253,874 $2.75 Million
Q1 2024 May 15, 2024	BUY	$10.95 - $16.62 $4,040 - $6,132	369 Added 0.15%	249,030 $2.82 Million
Q4 2023 Feb 14, 2024	BUY	$10.53 - $17.14 $2.47 Million - $4.01 Million	234,143 Added 1612.78%	248,661 $3.49 Million
Q3 2023 Nov 09, 2023	SELL	$8.19 - $12.98 $1.92 Million - $3.04 Million	-234,177 Reduced 94.16%	14,518 $179,000
Q2 2023 Aug 14, 2023	SELL	$3.22 - $9.65 $19,394 - $58,121	-6,023 Reduced 2.36%	248,695 $2.25 Million
Q1 2023 May 15, 2023	SELL	$2.55 - $4.97 $514,967 - $1 Million	-201,948 Reduced 44.22%	254,718 $883,000
Q2 2022 Aug 11, 2022	BUY	$2.04 - $4.61 $816,467 - $1.85 Million	400,229 Added 709.16%	456,666 $1.86 Million
Q1 2022 May 13, 2022	SELL	$3.89 - $9.43 $197,331 - $478,365	-50,728 Reduced 47.34%	56,437 $240,000
Q4 2021 Feb 11, 2022	BUY	$8.75 - $30.71 $8,575 - $30,095	980 Added 0.92%	107,165 $1 Million
Q3 2021 Nov 04, 2021	BUY	$22.96 - $30.13 $162,878 - $213,742	7,094 Added 7.16%	106,185 $2.93 Million
Q2 2021 Aug 11, 2021	BUY	$21.15 - $36.14 $1.81 Million - $3.09 Million	85,615 Added 635.31%	99,091 $2.77 Million
Q1 2021 May 13, 2021	BUY	$27.81 - $53.64 $374,767 - $722,852	13,476 New	13,476 $447,000

Others Institutions Holding OLMA

# of Institutions

136

Shares Held

58.7M

Call Options Held

141K

Put Options Held

23.1K

View Full List

About Olema Pharmaceuticals, Inc.

Ticker OLMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,419,600
Market Cap $355M
Description
Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clinical trial for the treatment of recurrent, local...

More about OLMA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account